Press Releases
Cassidy Tours Southeastern Louisiana University Head Start and Early Head Start Center
BATON ROUGE - U.S. Senator Bill Cassidy, M.D. (R-LA) today toured the Southeastern Louisiana University (SLU) Head Start and Early Head Start Center in Hammond. Cassidy assisted the Regina Coeli Child Development Center in securing critical grant funding from the Department of Health and Human Services so they could purchase new and replace 12 old modular buildings, as well as continue providing Head Start services in Livingston, St. Helena, St. Tammany, Tangipahoa, and Washington Parishes. "… Continue Reading
05.04.21
Cassidy Speaks to Louisiana Legislature
BATON ROUGE - U.S. Senator Bill Cassidy, M.D. (R-LA) today visited the Louisiana State Capitol to speak to the legislature, thank them for their work to improve our state and express his commitment to assisting their efforts in Congress. "Louisiana legislators on a federal and state level have to work together to achieve everything we can possibly achieve," said Dr. Cassidy. "I thank the Legislature for the opportunity to speak to them. More importantly, I thank them for their partnership." … Continue Reading
05.04.21
Ahead of Visit to Louisiana, Cassidy Urges Biden Administration to Support Disaster Relief
U.S. Senator Bill Cassidy (R-LA), along with U.S. Senator Jeff Merkley (D-OR), urged the Biden administration to support a supplemental disaster appropriations effort to direct urgently needed federal resources to communities throughout America that are struggling to recover from hurricanes, floods, wildfires, and other natural disasters that have occurred since the beginning of 2020. "According to the National Centers for Environmental Information, 2020 shattered the previous annual record for… Continue Reading
05.04.21
Cassidy, Hassan Urge Biden Administration to Implement No Surprise Act According to Congressional Intent
U.S. Senators Bill Cassidy, M.D. (R-LA) and Maggie Hassan (D-NH) urged the Biden Administration to implement legislation to end the practice of surprise medical billing according to congressional intent. In a letter sent to Health and Human Services Secretary Xavier Becerra, Treasury Secretary Janet Yellen, and Labor Secretary Marty Walsh, the senators highlighted several key areas of the No Surprises Act, which passed as part of the Consolidated Appropriations Act of 2021. "We wrote this law t… Continue Reading
05.04.21
Cassidy, Marshall, Smith Introduce Bipartisan Legislation to Harness Real-World Evidence in FDA Approval Process
U.S. Senators Bill Cassidy, M.D. (R-LA), Roger Marshall, M.D. (R-KS), and Tina Smith (D-MN) introduced bipartisan legislation to harness real-world evidence (RWE) gathered during emergency use authorization (EUA) to support future approvals for drugs, biologics, and medical devices at the U.S. Food and Drug Administration (FDA). This legislation would enable the FDA to develop a clear framework for how it uses RWE in premarket approvals ranging from drugs and vaccines to medical devices. Not onl… Continue Reading
05.03.21
Cassidy Announces Major PPE Manufacturer in Broussard
LAFAYETTE - U.S. Senator Bill Cassidy, M.D. (R-LA) today helped announce that Ochsner Health and Trax Development have launched SafeSource Direct, LLC, which will have two facilities in Broussard that manufacture personal protective equipment (PPE) for use in the United States. The Senator was joined by Governor John Bel Edwards, Lafayette Parish President Josh Guillory, St. Martin Parish President Chester Cedars and Broussard Mayor Ray Bourque. "The pandemic showed that America needs to make… Continue Reading
05.03.21
Cassidy, Hoeven, Colleagues Press FERC to Act on Pending Natural Gas Pipeline Projects
U.S. Senator Bill Cassidy, M.D. (R-LA) joined U.S. Senator John Hoeven (R-ND) and a group of 24 bipartisan senators in pressing the Federal Energy and Regulatory Commission (FERC) to act on vital energy infrastructure projects by reviewing, without further delay, the 14 natural gas pipeline infrastructure projects that are currently pending before FERC. In the letter to the FERC chairman and commissioners, the senators also outlined the importance of reviewing the projects using current FERC gui… Continue Reading
05.02.21
ICYMI: Cassidy Discusses Infrastructure, Taxes and Calls for Honesty from Biden Administration on Fox News Sunday
U.S. Senator Bill Cassidy, M.D. (R-LA) today joined Chris Wallace on Fox News Sunday calling on the need for honesty from the Biden administration. During the interview they discussed President Biden's push for big government, the economy, taxes and infrastructure. On Biden's Push for Big Government "The era of big government coming back will thwart the progress we need to make. And I think we can see recent history about how that is exactly true." On the Economy "The aspiration of this Bid… Continue Reading
04.30.21
Cassidy, McConnell, Colleagues Demand Biden Administration Withdraws Department of Education’s Politicized Civics Grant Programs
U.S. Senators Bill Cassidy, M.D. (R-LA) and Republican Senate Leader Mitch McConnell (R-KY) led a group of 36 of their Senate colleagues in demanding the U.S. Department of Education withdraw a divisive, political grant program on civic education. The Department is attempting to radicalize American History and Civics Education programs, including the Presidential and Congressional Academies for American History and Civics and the National Activities programs. The letter states: "This is a time… Continue Reading
04.30.21
Cassidy, Cotton, Colleagues Condemn Amazon for Removing Justice Clarence Thomas Documentary
U.S. Senators Bill Cassidy, M.D. (R-LA) joined U.S. Senator Tom Cotton (R-AR) and 18 Senate colleagues in a letter to Jeffrey Bezos questioning why Created Equal: Clarence Thomas in His Own Words, a documentary about the life of U.S. Supreme Court Justice Clarence Thomas, was removed from Amazon's streaming service. The film's removal came during Black History Month. The letter stated: "We write concerning Amazon's latest effort to target conservative Americans. On February 8, 2021, in the mid… Continue Reading
04.29.21
Cassidy, Smith Introduce Bills to Lower Drugs Costs by Speeding Up Development of and Improving Access to Generics
U.S. Senators Bill Cassidy, M.D. (R-LA) and Tina Smith (D-MN) today introduced two bills, the Simplifying the Generic Drug Application Process Act and the Modernizing Therapeutic Equivalence Rating Determination Act, to speed the development of and improve access to lower-cost generic drugs. These bills make changes to the Food Drug and Cosmetic Act (FDCA) and 505(b)(2) approval pathway, which will make it easier for generics to come to market driving up competition and driving down drug prices.… Continue Reading
04.29.21
Cassidy, Kaine, Moran, Warner Introduce Bipartisan Bill to Support Childhood Cancer Research
U.S. Senators Bill Cassidy (R-LA), Tim Kaine (D-VA), Jerry Moran (R-KS), and Mark Warner (D-VA) introduced the Gabriella Miller Kids First Research Act 2.0. This legislation would provide a new source of funding for the National Institutes of Health's (NIH) Gabriella Miller Kids First Pediatric Research Program (Kids First) by redirecting penalties collected from pharmaceutical, cosmetic, supplement, and medical device companies that break the law to pediatric and childhood cancer research. The… Continue Reading
04.29.21
Cassidy, Casey Introduce Bipartisan Pregnant Workers Fairness Act, Propose Protections Against Workplace Discrimination
As millions of American women remain in the essential workforce during the COVID-19 pandemic, U.S. Senators Bill Cassidy, M.D. (R-LA), Bob Casey (D-PA), Jeanne Shaheen (D-NH), Shelley Moore Capito (R-WV) and Lisa Murkowski (R-AK) are introducing the bipartisan Pregnant Workers Fairness Act to protect pregnant workers from workplace discrimination. This legislation, which is closely modeled after the Americans with Disabilities Act (ADA), would require employers to make reasonable accommodations … Continue Reading
04.28.21
VIDEO: Cassidy Statement on President Biden’s Joint Address to Congress
(Click here to download Senator Cassidy's statement or here to watch on YouTube.) WASHINGTON - U.S. Senator Bill Cassidy, M.D. (R-LA) released the following statement after President Biden delivered his Joint Address to Congress tonight. "Tonight we heard a huge contrast between two visions. Democrats are embracing tax and spend with government control. Republicans, we're doubling down. We're the party of opportunity," said Dr. Cassidy. "We heard a really great message from Senator Tim Scott… Continue Reading
04.28.21
Cassidy, Colleagues Reintroduce Bill To Promote U.S. Shark Conservation As A Global Model Of Sustainability
U.S. Senators Bill Cassidy, M.D. (R-LA), Marco Rubio (R-FL), Rick Scott (R-FL), and Mike Braun (R-IN) reintroduced the Sustainable Shark Fisheries and Trade Act, legislation that recognizes the sustainable and economically valuable fishing practices of U.S. shark fishermen and promotes U.S. standards for shark conservation and humane harvest abroad. The bill was first introduced in April 2018 and was approved by the Senate Commerce Committee in May 2018. "Louisiana shark fishermen should not ha… Continue Reading
04.28.21
Cassidy, Colleagues Introduce Bicameral Legislation Banning Abortion Providers from PPP Participation
U.S. Senators Bill Cassidy, M.D. (R-LA), Roger Marshall, M.D. (R-KS), U.S. Representative Greg Murphy, M.D. (R-NC-03), and 86 House and Senate colleagues introduced the Abortion Providers Loan Elimination (APLE) Act, which requires Planned Parenthood affiliates to return the $80 million in Paycheck Protection Program (PPP) loans they illegally applied for and received. It would also ensure Planned Parenthood affiliates, and other abortion providers, remain ineligible for future PPP funding and i… Continue Reading
04.26.21
Cassidy, 115 Colleagues Urge FDA to Protect Women and Babies from the Consequences of Chemical Abortions
U.S. Senator Bill Cassidy, M.D. (R-LA) joined 115 of his House and Senate colleagues in opposition to weakening the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone - a chemical abortion drug - in a letter sent to the U.S. Food and Drug Administration (FDA). The Biden administration recently took action not to enforce REMS for mifepristone for the remainder of the COVID-19 public health emergency. The letter stated: "In addition to the loss of the unborn child, mifepristone pre… Continue Reading
04.26.21
Cassidy, Smith Introduce Bipartisan Legislation to Improve U.S. Supply Chain for Critical Antibiotics
U.S. Senators Bill Cassidy, M.D. (R-LA) and Tina Smith (D-MN) introduced bipartisan legislation to improve the United States' supply chain for critical antibiotics and address the threat of antibiotic resistance. The Onshoring Essential Antibiotics Act would provide $500 million in grants to build and improve manufacturing facilities. It would also commission a study to determine which essential antibiotics are most vulnerable to foreign supply chain disruptions, as well as allow the Health and … Continue Reading
04.26.21
Growing Support for College Transparency Act with Quarter of Senate Signed on as Cosponsors
U.S. Senators Bill Cassidy, M.D. (R-LA), Elizabeth Warren (D-MA), Tim Scott (R-SC), and Sheldon Whitehouse (D-RI) today announced 25 senators have signed their names onto the bipartisan College Transparency Act (CTA). "If you're a student, you'd like to know if you go to a particular university in a particular curriculum what's the likelihood to graduate, get a good job, and average amount of student loan debt. Those are all things the College Transparency Act provides while protecting student… Continue Reading
04.23.21
Cassidy, Smith, Marshall Bipartisan Legislation to Lower Prescription Drug Costs Signed into Law by President
Today, the president signed into law bipartisan legislation, the Ensuring Innovation Act, introduced by U.S. Senators Bill Cassidy, M.D. (R-LA), Tina Smith (D-MN), and Roger Marshall, M.D. (R-KS) to help lower prescription drug prices. The legislation will provide clarity for drug exclusivity to prevent awarding market exclusivity to products that do not represent true innovation and unduly delay cheaper generics from entering the market. "Listening to patients and people back home, I hear the… Continue Reading
